ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,941Medicare Part D Prescriptions Filled, Including Refills

Rank: 231 out of 972

$442K Total Retail Price of All Prescriptions

Rank: 383 out of 972

531 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

21% of this provider’s 531 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 9,827 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 706 638 1 2
LISINOPRIL 668 605 2 1
AMLODIPINE BESYLATE 526 480 3 4
HYDROCODONE-ACETAMINOPHEN 375 303 S3 4 6
LEVOTHYROXINE SODIUM 306 289 5 3
METFORMIN HCL 269 248 6 8
METOPROLOL TARTRATE 266 247 7 9
WARFARIN SODIUM 258 238 8 12
LOSARTAN POTASSIUM 246 227 9 17
ALENDRONATE SODIUM 224 197 10 27
FUROSEMIDE 221 215 11 7
ZOLPIDEM TARTRATE 207 192 12 23
DILTIAZEM 24HR CD 180 177 13 74
DOXAZOSIN MESYLATE 174 163 14 82
METOPROLOL SUCCINATE 171 140 15 16
TRIAMTERENE-HCTZ 171 158 15 39
HYDROCHLOROTHIAZIDE 170 160 17 10
CARVEDILOL 169 153 18 21
POTASSIUM CHLORIDE 154 140 19 13
OMEPRAZOLE 153 128 20 5
TRAMADOL HCL 151 141 21 15
ATORVASTATIN CALCIUM 142 141 22 11
LOVASTATIN 126 118 23 22
SERTRALINE HCL 126 87 23 25
GABAPENTIN 124 109 25 14
RANITIDINE HCL 124 124 25 24
TAMSULOSIN HCL 108 98 27 29
DILTIAZEM 24HR ER 98 98 28 207
ALLOPURINOL 95 81 29 28
GLIPIZIDE 92 90 30 59
ENALAPRIL MALEATE 90 90 31 50
AZITHROMYCIN 90 78 31 42
ATENOLOL 80 80 33 18
FINASTERIDE 76 76 34 77
PROAIR HFA 76 67 34 47
EVISTA 75 75 36 127
ISOSORBIDE MONONITRATE ER 75 75 36 43
CLOPIDOGREL 74 71 38 37
CITALOPRAM HBR 70 34 39 19
METHYLPREDNISOLONE 65 58 40 119
ADVAIR DISKUS 63 54 41 45
HYDRALAZINE HCL 63 43 41 69
NIASPAN 60 56 43 144
CIPROFLOXACIN HCL 58 54 44 63
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 56 45 32
PROPRANOLOL HCL 54 45 46 118
ACTONEL 53 53 47 231
AMITRIPTYLINE HCL 53 53 R 47 58
CLONIDINE 53 53 47 411
CLONIDINE HCL 52 35 50 57
DOXYCYCLINE HYCLATE 52 43 50 117
PREDNISONE 51 44 52 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.